nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA7—renal system—muscle cancer	0.0129	0.0739	CbGeAlD
Dorzolamide—CA14—cardiac atrium—muscle cancer	0.00959	0.0551	CbGeAlD
Dorzolamide—CA9—tendon—muscle cancer	0.00881	0.0507	CbGeAlD
Dorzolamide—CA14—tendon—muscle cancer	0.00836	0.0481	CbGeAlD
Dorzolamide—CA12—renal system—muscle cancer	0.00835	0.048	CbGeAlD
Dorzolamide—CA6—head—muscle cancer	0.00833	0.0479	CbGeAlD
Dorzolamide—CA9—testis—muscle cancer	0.00729	0.042	CbGeAlD
Dorzolamide—CA5B—cardiac atrium—muscle cancer	0.00671	0.0386	CbGeAlD
Dorzolamide—CA1—renal system—muscle cancer	0.00661	0.038	CbGeAlD
Dorzolamide—CA5B—tendon—muscle cancer	0.00585	0.0336	CbGeAlD
Dorzolamide—CA2—embryo—muscle cancer	0.00566	0.0326	CbGeAlD
Dorzolamide—Erectile dysfunction—Vincristine—muscle cancer	0.00561	0.00679	CcSEcCtD
Dorzolamide—CA12—head—muscle cancer	0.00559	0.0321	CbGeAlD
Dorzolamide—Weight decreased—Vincristine—muscle cancer	0.00551	0.00667	CcSEcCtD
Dorzolamide—Cardiac arrest—Etoposide—muscle cancer	0.00543	0.00657	CcSEcCtD
Dorzolamide—CA5B—vagina—muscle cancer	0.00542	0.0312	CbGeAlD
Dorzolamide—Pharyngitis—Dactinomycin—muscle cancer	0.00542	0.00656	CcSEcCtD
Dorzolamide—Depression—Vincristine—muscle cancer	0.00542	0.00656	CcSEcCtD
Dorzolamide—Scotoma—Doxorubicin—muscle cancer	0.00537	0.0065	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Vincristine—muscle cancer	0.00536	0.00648	CcSEcCtD
Dorzolamide—Rash erythematous—Doxorubicin—muscle cancer	0.00533	0.00645	CcSEcCtD
Dorzolamide—Myocardial infarction—Vincristine—muscle cancer	0.00533	0.00645	CcSEcCtD
Dorzolamide—Sweating—Vincristine—muscle cancer	0.00521	0.0063	CcSEcCtD
Dorzolamide—CA4—renal system—muscle cancer	0.00517	0.0297	CbGeAlD
Dorzolamide—Erythema multiforme—Dactinomycin—muscle cancer	0.00516	0.00625	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00514	0.00622	CcSEcCtD
Dorzolamide—Stinging—Doxorubicin—muscle cancer	0.00504	0.0061	CcSEcCtD
Dorzolamide—CA5B—head—muscle cancer	0.00501	0.0288	CbGeAlD
Dorzolamide—CA1—bone marrow—muscle cancer	0.005	0.0288	CbGeAlD
Dorzolamide—Bronchospasm—Etoposide—muscle cancer	0.00486	0.00588	CcSEcCtD
Dorzolamide—Hallucination—Vincristine—muscle cancer	0.00485	0.00587	CcSEcCtD
Dorzolamide—CA5B—testis—muscle cancer	0.00484	0.0278	CbGeAlD
Dorzolamide—Alopecia—Dactinomycin—muscle cancer	0.00482	0.00584	CcSEcCtD
Dorzolamide—Respiratory failure—Methotrexate—muscle cancer	0.0048	0.00581	CcSEcCtD
Dorzolamide—Erythema—Dactinomycin—muscle cancer	0.00475	0.00575	CcSEcCtD
Dorzolamide—Vasodilation—Doxorubicin—muscle cancer	0.00464	0.00562	CcSEcCtD
Dorzolamide—Vasodilation procedure—Doxorubicin—muscle cancer	0.00464	0.00562	CcSEcCtD
Dorzolamide—CA4—cardiac atrium—muscle cancer	0.00463	0.0266	CbGeAlD
Dorzolamide—CA2—smooth muscle tissue—muscle cancer	0.00445	0.0256	CbGeAlD
Dorzolamide—Lacrimation increased—Doxorubicin—muscle cancer	0.00443	0.00536	CcSEcCtD
Dorzolamide—CA1—head—muscle cancer	0.00442	0.0255	CbGeAlD
Dorzolamide—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00436	0.00528	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Etoposide—muscle cancer	0.00434	0.00525	CcSEcCtD
Dorzolamide—Myocardial infarction—Etoposide—muscle cancer	0.00431	0.00522	CcSEcCtD
Dorzolamide—Alopecia—Vincristine—muscle cancer	0.00431	0.00522	CcSEcCtD
Dorzolamide—CA2—renal system—muscle cancer	0.00429	0.0247	CbGeAlD
Dorzolamide—Atrioventricular block—Doxorubicin—muscle cancer	0.00421	0.00509	CcSEcCtD
Dorzolamide—Pulmonary oedema—Methotrexate—muscle cancer	0.00419	0.00508	CcSEcCtD
Dorzolamide—Agranulocytosis—Etoposide—muscle cancer	0.00411	0.00497	CcSEcCtD
Dorzolamide—Back pain—Vincristine—muscle cancer	0.00411	0.00497	CcSEcCtD
Dorzolamide—CA4—tendon—muscle cancer	0.00403	0.0232	CbGeAlD
Dorzolamide—Abnormal dreams—Doxorubicin—muscle cancer	0.00403	0.00488	CcSEcCtD
Dorzolamide—Dermatitis contact—Doxorubicin—muscle cancer	0.00403	0.00488	CcSEcCtD
Dorzolamide—Discomfort—Dactinomycin—muscle cancer	0.004	0.00484	CcSEcCtD
Dorzolamide—CA4—bone marrow—muscle cancer	0.00391	0.0225	CbGeAlD
Dorzolamide—Oedema—Dactinomycin—muscle cancer	0.00388	0.00469	CcSEcCtD
Dorzolamide—Blood urea increased—Doxorubicin—muscle cancer	0.00385	0.00466	CcSEcCtD
Dorzolamide—CA2—cardiac atrium—muscle cancer	0.00384	0.0221	CbGeAlD
Dorzolamide—Vertigo—Vincristine—muscle cancer	0.00381	0.00462	CcSEcCtD
Dorzolamide—Dry eye—Doxorubicin—muscle cancer	0.00377	0.00456	CcSEcCtD
Dorzolamide—Erythema multiforme—Etoposide—muscle cancer	0.00374	0.00452	CcSEcCtD
Dorzolamide—Anorexia—Dactinomycin—muscle cancer	0.0037	0.00447	CcSEcCtD
Dorzolamide—Hypertension—Vincristine—muscle cancer	0.00367	0.00444	CcSEcCtD
Dorzolamide—Pulmonary oedema—Doxorubicin—muscle cancer	0.00363	0.0044	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00363	0.00439	CcSEcCtD
Dorzolamide—Visual disturbance—Methotrexate—muscle cancer	0.00361	0.00437	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00353	0.00428	CcSEcCtD
Dorzolamide—Alopecia—Etoposide—muscle cancer	0.00349	0.00423	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Methotrexate—muscle cancer	0.00349	0.00423	CcSEcCtD
Dorzolamide—Anaphylactic shock—Vincristine—muscle cancer	0.00346	0.00419	CcSEcCtD
Dorzolamide—Oedema—Vincristine—muscle cancer	0.00346	0.00419	CcSEcCtD
Dorzolamide—CA4—head—muscle cancer	0.00346	0.0199	CbGeAlD
Dorzolamide—Decreased appetite—Dactinomycin—muscle cancer	0.00337	0.00408	CcSEcCtD
Dorzolamide—Dysgeusia—Etoposide—muscle cancer	0.00337	0.00408	CcSEcCtD
Dorzolamide—Hyperhidrosis—Vincristine—muscle cancer	0.00335	0.00405	CcSEcCtD
Dorzolamide—CA2—tendon—muscle cancer	0.00335	0.0192	CbGeAlD
Dorzolamide—Fatigue—Dactinomycin—muscle cancer	0.00334	0.00405	CcSEcCtD
Dorzolamide—CA4—testis—muscle cancer	0.00334	0.0192	CbGeAlD
Dorzolamide—Back pain—Etoposide—muscle cancer	0.00333	0.00403	CcSEcCtD
Dorzolamide—Pain—Dactinomycin—muscle cancer	0.00332	0.00401	CcSEcCtD
Dorzolamide—Anorexia—Vincristine—muscle cancer	0.0033	0.004	CcSEcCtD
Dorzolamide—Eye pain—Doxorubicin—muscle cancer	0.00328	0.00397	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00327	0.00395	CcSEcCtD
Dorzolamide—CA2—bone marrow—muscle cancer	0.00324	0.0186	CbGeAlD
Dorzolamide—Mood swings—Methotrexate—muscle cancer	0.00324	0.00392	CcSEcCtD
Dorzolamide—Hypotension—Vincristine—muscle cancer	0.00324	0.00392	CcSEcCtD
Dorzolamide—Feeling abnormal—Dactinomycin—muscle cancer	0.0032	0.00387	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00317	0.00384	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00316	0.00382	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00314	0.0038	CcSEcCtD
Dorzolamide—Insomnia—Vincristine—muscle cancer	0.00313	0.00379	CcSEcCtD
Dorzolamide—Paraesthesia—Vincristine—muscle cancer	0.00311	0.00377	CcSEcCtD
Dorzolamide—CA2—vagina—muscle cancer	0.0031	0.0179	CbGeAlD
Dorzolamide—Vertigo—Etoposide—muscle cancer	0.00309	0.00374	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00308	0.00373	CcSEcCtD
Dorzolamide—Abdominal pain—Dactinomycin—muscle cancer	0.00307	0.00371	CcSEcCtD
Dorzolamide—Body temperature increased—Dactinomycin—muscle cancer	0.00307	0.00371	CcSEcCtD
Dorzolamide—Hypoglycaemia—Doxorubicin—muscle cancer	0.00304	0.00367	CcSEcCtD
Dorzolamide—Cardiac failure—Doxorubicin—muscle cancer	0.00304	0.00367	CcSEcCtD
Dorzolamide—Loss of consciousness—Etoposide—muscle cancer	0.00302	0.00366	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00302	0.00366	CcSEcCtD
Dorzolamide—Decreased appetite—Vincristine—muscle cancer	0.00301	0.00365	CcSEcCtD
Dorzolamide—Cough—Etoposide—muscle cancer	0.003	0.00363	CcSEcCtD
Dorzolamide—Fatigue—Vincristine—muscle cancer	0.00299	0.00362	CcSEcCtD
Dorzolamide—Hypertension—Etoposide—muscle cancer	0.00297	0.00359	CcSEcCtD
Dorzolamide—Pain—Vincristine—muscle cancer	0.00296	0.00359	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—muscle cancer	0.00296	0.00359	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—muscle cancer	0.00296	0.00359	CcSEcCtD
Dorzolamide—Chest pain—Etoposide—muscle cancer	0.00293	0.00354	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—muscle cancer	0.00292	0.00353	CcSEcCtD
Dorzolamide—Discomfort—Etoposide—muscle cancer	0.00289	0.0035	CcSEcCtD
Dorzolamide—CA2—head—muscle cancer	0.00287	0.0165	CbGeAlD
Dorzolamide—Hypersensitivity—Dactinomycin—muscle cancer	0.00286	0.00346	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Vincristine—muscle cancer	0.00283	0.00343	CcSEcCtD
Dorzolamide—Confusional state—Etoposide—muscle cancer	0.00283	0.00343	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—muscle cancer	0.00282	0.00341	CcSEcCtD
Dorzolamide—Anaphylactic shock—Etoposide—muscle cancer	0.00281	0.0034	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—muscle cancer	0.00281	0.0034	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—muscle cancer	0.00278	0.00337	CcSEcCtD
Dorzolamide—CA2—testis—muscle cancer	0.00277	0.0159	CbGeAlD
Dorzolamide—CYP3A4—renal system—muscle cancer	0.00277	0.0159	CbGeAlD
Dorzolamide—Dysuria—Methotrexate—muscle cancer	0.00276	0.00335	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00275	0.00333	CcSEcCtD
Dorzolamide—Body temperature increased—Vincristine—muscle cancer	0.00274	0.00332	CcSEcCtD
Dorzolamide—Abdominal pain—Vincristine—muscle cancer	0.00274	0.00332	CcSEcCtD
Dorzolamide—Erectile dysfunction—Methotrexate—muscle cancer	0.00272	0.0033	CcSEcCtD
Dorzolamide—Hyperhidrosis—Etoposide—muscle cancer	0.00271	0.00328	CcSEcCtD
Dorzolamide—Anorexia—Etoposide—muscle cancer	0.00268	0.00324	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00267	0.00323	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—muscle cancer	0.00265	0.00321	CcSEcCtD
Dorzolamide—Depression—Methotrexate—muscle cancer	0.00263	0.00318	CcSEcCtD
Dorzolamide—Hypotension—Etoposide—muscle cancer	0.00262	0.00317	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00261	0.00316	CcSEcCtD
Dorzolamide—Conjunctivitis—Methotrexate—muscle cancer	0.00256	0.0031	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—muscle cancer	0.00256	0.0031	CcSEcCtD
Dorzolamide—Hypersensitivity—Vincristine—muscle cancer	0.00255	0.00309	CcSEcCtD
Dorzolamide—Sweating—Methotrexate—muscle cancer	0.00253	0.00306	CcSEcCtD
Dorzolamide—Paraesthesia—Etoposide—muscle cancer	0.00252	0.00305	CcSEcCtD
Dorzolamide—Dyspnoea—Etoposide—muscle cancer	0.0025	0.00303	CcSEcCtD
Dorzolamide—Somnolence—Etoposide—muscle cancer	0.0025	0.00302	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—muscle cancer	0.00249	0.00302	CcSEcCtD
Dorzolamide—Epistaxis—Methotrexate—muscle cancer	0.00249	0.00301	CcSEcCtD
Dorzolamide—Asthenia—Vincristine—muscle cancer	0.00249	0.00301	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—muscle cancer	0.00247	0.00298	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—muscle cancer	0.00246	0.00298	CcSEcCtD
Dorzolamide—Agranulocytosis—Methotrexate—muscle cancer	0.00246	0.00298	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—muscle cancer	0.00245	0.00296	CcSEcCtD
Dorzolamide—Decreased appetite—Etoposide—muscle cancer	0.00244	0.00295	CcSEcCtD
Dorzolamide—Fatigue—Etoposide—muscle cancer	0.00242	0.00293	CcSEcCtD
Dorzolamide—Pain—Etoposide—muscle cancer	0.0024	0.00291	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—muscle cancer	0.00239	0.0029	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00238	0.00288	CcSEcCtD
Dorzolamide—Diarrhoea—Vincristine—muscle cancer	0.00237	0.00287	CcSEcCtD
Dorzolamide—Pharyngitis—Methotrexate—muscle cancer	0.00235	0.00284	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—muscle cancer	0.00232	0.0028	CcSEcCtD
Dorzolamide—Feeling abnormal—Etoposide—muscle cancer	0.00231	0.0028	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—muscle cancer	0.00231	0.0028	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—muscle cancer	0.0023	0.00279	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Etoposide—muscle cancer	0.0023	0.00278	CcSEcCtD
Dorzolamide—Dizziness—Vincristine—muscle cancer	0.00229	0.00277	CcSEcCtD
Dorzolamide—Visual impairment—Methotrexate—muscle cancer	0.00228	0.00276	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00226	0.00274	CcSEcCtD
Dorzolamide—Erythema multiforme—Methotrexate—muscle cancer	0.00224	0.00271	CcSEcCtD
Dorzolamide—Urticaria—Etoposide—muscle cancer	0.00223	0.0027	CcSEcCtD
Dorzolamide—Abdominal pain—Etoposide—muscle cancer	0.00222	0.00269	CcSEcCtD
Dorzolamide—Body temperature increased—Etoposide—muscle cancer	0.00222	0.00269	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—muscle cancer	0.00222	0.00269	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—muscle cancer	0.00222	0.00269	CcSEcCtD
Dorzolamide—Tinnitus—Methotrexate—muscle cancer	0.00221	0.00267	CcSEcCtD
Dorzolamide—Vomiting—Vincristine—muscle cancer	0.0022	0.00267	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—muscle cancer	0.00219	0.00265	CcSEcCtD
Dorzolamide—Rash—Vincristine—muscle cancer	0.00218	0.00264	CcSEcCtD
Dorzolamide—Dermatitis—Vincristine—muscle cancer	0.00218	0.00264	CcSEcCtD
Dorzolamide—Headache—Vincristine—muscle cancer	0.00217	0.00263	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—muscle cancer	0.00215	0.00261	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—muscle cancer	0.00214	0.00259	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—muscle cancer	0.00213	0.00258	CcSEcCtD
Dorzolamide—Alopecia—Methotrexate—muscle cancer	0.00209	0.00253	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—muscle cancer	0.00209	0.00253	CcSEcCtD
Dorzolamide—Hypersensitivity—Etoposide—muscle cancer	0.00207	0.0025	CcSEcCtD
Dorzolamide—Erythema—Methotrexate—muscle cancer	0.00206	0.00249	CcSEcCtD
Dorzolamide—Nausea—Vincristine—muscle cancer	0.00206	0.00249	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—muscle cancer	0.00203	0.00246	CcSEcCtD
Dorzolamide—Dysgeusia—Methotrexate—muscle cancer	0.00202	0.00244	CcSEcCtD
Dorzolamide—Asthenia—Etoposide—muscle cancer	0.00201	0.00244	CcSEcCtD
Dorzolamide—Back pain—Methotrexate—muscle cancer	0.00199	0.00241	CcSEcCtD
Dorzolamide—Pruritus—Etoposide—muscle cancer	0.00199	0.0024	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—muscle cancer	0.00197	0.00239	CcSEcCtD
Dorzolamide—Vision blurred—Methotrexate—muscle cancer	0.00194	0.00235	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—muscle cancer	0.00194	0.00235	CcSEcCtD
Dorzolamide—Diarrhoea—Etoposide—muscle cancer	0.00192	0.00232	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—muscle cancer	0.00191	0.00231	CcSEcCtD
Dorzolamide—Dizziness—Etoposide—muscle cancer	0.00186	0.00225	CcSEcCtD
Dorzolamide—Vertigo—Methotrexate—muscle cancer	0.00185	0.00224	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—muscle cancer	0.00183	0.00222	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—muscle cancer	0.00181	0.00219	CcSEcCtD
Dorzolamide—Cough—Methotrexate—muscle cancer	0.0018	0.00218	CcSEcCtD
Dorzolamide—Vomiting—Etoposide—muscle cancer	0.00178	0.00216	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—muscle cancer	0.00178	0.00216	CcSEcCtD
Dorzolamide—Rash—Etoposide—muscle cancer	0.00177	0.00214	CcSEcCtD
Dorzolamide—Dermatitis—Etoposide—muscle cancer	0.00177	0.00214	CcSEcCtD
Dorzolamide—Headache—Etoposide—muscle cancer	0.00176	0.00213	CcSEcCtD
Dorzolamide—Chest pain—Methotrexate—muscle cancer	0.00175	0.00212	CcSEcCtD
Dorzolamide—Arthralgia—Methotrexate—muscle cancer	0.00175	0.00212	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—muscle cancer	0.00175	0.00212	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—muscle cancer	0.00175	0.00211	CcSEcCtD
Dorzolamide—Discomfort—Methotrexate—muscle cancer	0.00173	0.0021	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—muscle cancer	0.00173	0.0021	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—muscle cancer	0.00173	0.00209	CcSEcCtD
Dorzolamide—Confusional state—Methotrexate—muscle cancer	0.0017	0.00205	CcSEcCtD
Dorzolamide—Anaphylactic shock—Methotrexate—muscle cancer	0.00168	0.00204	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—muscle cancer	0.00168	0.00203	CcSEcCtD
Dorzolamide—Nausea—Etoposide—muscle cancer	0.00167	0.00202	CcSEcCtD
Dorzolamide—Hyperhidrosis—Methotrexate—muscle cancer	0.00163	0.00197	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—muscle cancer	0.0016	0.00194	CcSEcCtD
Dorzolamide—Anorexia—Methotrexate—muscle cancer	0.0016	0.00194	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—muscle cancer	0.0016	0.00194	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—muscle cancer	0.00158	0.00191	CcSEcCtD
Dorzolamide—Hypotension—Methotrexate—muscle cancer	0.00157	0.0019	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—muscle cancer	0.00157	0.0019	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—muscle cancer	0.00156	0.00188	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—muscle cancer	0.00154	0.00186	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00153	0.00185	CcSEcCtD
Dorzolamide—Insomnia—Methotrexate—muscle cancer	0.00152	0.00184	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—muscle cancer	0.00152	0.00184	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—muscle cancer	0.00152	0.00184	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—muscle cancer	0.00151	0.00183	CcSEcCtD
Dorzolamide—Paraesthesia—Methotrexate—muscle cancer	0.00151	0.00183	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—muscle cancer	0.0015	0.00182	CcSEcCtD
Dorzolamide—Dyspnoea—Methotrexate—muscle cancer	0.0015	0.00181	CcSEcCtD
Dorzolamide—Somnolence—Methotrexate—muscle cancer	0.00149	0.00181	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—muscle cancer	0.00149	0.0018	CcSEcCtD
Dorzolamide—Dyspepsia—Methotrexate—muscle cancer	0.00148	0.00179	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—muscle cancer	0.00147	0.00178	CcSEcCtD
Dorzolamide—Decreased appetite—Methotrexate—muscle cancer	0.00146	0.00177	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—muscle cancer	0.00146	0.00176	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—muscle cancer	0.00146	0.00176	CcSEcCtD
Dorzolamide—Fatigue—Methotrexate—muscle cancer	0.00145	0.00175	CcSEcCtD
Dorzolamide—Pain—Methotrexate—muscle cancer	0.00144	0.00174	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—muscle cancer	0.00143	0.00173	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—muscle cancer	0.00141	0.0017	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—muscle cancer	0.00139	0.00168	CcSEcCtD
Dorzolamide—Feeling abnormal—Methotrexate—muscle cancer	0.00139	0.00168	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00137	0.00166	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—muscle cancer	0.00136	0.00165	CcSEcCtD
Dorzolamide—Urticaria—Methotrexate—muscle cancer	0.00134	0.00162	CcSEcCtD
Dorzolamide—Body temperature increased—Methotrexate—muscle cancer	0.00133	0.00161	CcSEcCtD
Dorzolamide—Abdominal pain—Methotrexate—muscle cancer	0.00133	0.00161	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00133	0.00161	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—muscle cancer	0.00132	0.00159	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—muscle cancer	0.00131	0.00158	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—muscle cancer	0.0013	0.00157	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—muscle cancer	0.00129	0.00157	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—muscle cancer	0.00128	0.00155	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—muscle cancer	0.00127	0.00153	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—muscle cancer	0.00126	0.00152	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—muscle cancer	0.00124	0.00151	CcSEcCtD
Dorzolamide—Hypersensitivity—Methotrexate—muscle cancer	0.00124	0.0015	CcSEcCtD
Dorzolamide—Asthenia—Methotrexate—muscle cancer	0.00121	0.00146	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—muscle cancer	0.0012	0.00145	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00119	0.00144	CcSEcCtD
Dorzolamide—Pruritus—Methotrexate—muscle cancer	0.00119	0.00144	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—muscle cancer	0.00116	0.0014	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—muscle cancer	0.00115	0.00139	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—muscle cancer	0.00115	0.00139	CcSEcCtD
Dorzolamide—Diarrhoea—Methotrexate—muscle cancer	0.00115	0.00139	CcSEcCtD
Dorzolamide—Dizziness—Methotrexate—muscle cancer	0.00111	0.00135	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—muscle cancer	0.00107	0.0013	CcSEcCtD
Dorzolamide—Vomiting—Methotrexate—muscle cancer	0.00107	0.00129	CcSEcCtD
Dorzolamide—Rash—Methotrexate—muscle cancer	0.00106	0.00128	CcSEcCtD
Dorzolamide—Dermatitis—Methotrexate—muscle cancer	0.00106	0.00128	CcSEcCtD
Dorzolamide—Headache—Methotrexate—muscle cancer	0.00105	0.00127	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—muscle cancer	0.00104	0.00126	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—muscle cancer	0.00103	0.00125	CcSEcCtD
Dorzolamide—Nausea—Methotrexate—muscle cancer	0.000999	0.00121	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—muscle cancer	0.000996	0.00121	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—muscle cancer	0.000963	0.00117	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—muscle cancer	0.000926	0.00112	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—muscle cancer	0.000918	0.00111	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—muscle cancer	0.000917	0.00111	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—muscle cancer	0.000912	0.0011	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—muscle cancer	0.000865	0.00105	CcSEcCtD
